Category: Uncategorized

Genentech, a member of the Roche Group, has announced a significant expansion of its initial investment in a new manufacturing... Read more

Tesaro, an oncology-focused subsidiary of GSK, has entered into a global licensing agreement with South Korea’s Alteogen to develop a... Read more

Global contract research organization (CRO) Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research. The... Read more

In a significant corporate reshuffle, Japanese pharmaceutical firm Shionogi & Co. has committed an additional $2.13 billion to increase its... Read more

In its first major M&A move under new CEO Luke Miels, GSK has reached a definitive agreement to acquire California-based... Read more

U.S. pharmaceutical giant Pfizer has agreed to divest its entire interest in ViiV Healthcare, a global specialist in HIV treatment,... Read more

The French biotech firm Valneva has announced the permanent withdrawal of its chikungunya vaccine, Ixchiq, from the United States. This... Read more

Pharmaceutical giant Takeda is implementing a new round of job cuts in the United States as it prepares for the... Read more

Pharmaceutical giant GSK is undertaking a strategic move to optimize the administration of its flagship immunotherapy through a new technological... Read more